We uncover a mechanism that LL37 can remarkably inhibit the SARS‐CoV‐2‐induced membrane fusion activity with host cells and infection through binding to the spike S2 subunit and blocking TMPRSS2‐mediated S2' priming process. The gene discussed is TMPRSS2; the disease is infection.